Cooperative Roles of Hydrophilic Loop 1 and the C-Terminus of Presenilin 1 in the Substrate-Gating Mechanism of γ-Secretase

γ-Secretase is a multisubunit protease complex that is responsible for generating amyloid-β peptides, which are associated with Alzheimer disease. The catalytic subunit of γ-secretase is presenilin 1 (PS1), which contains an initial substrate-binding site that is distinct from the catalytic site. Processive cleavage is suggested in the intramembrane-cleaving mechanism of γ-secretase. However, it largely remains unknown as to how γ-secretase recognizes its substrate during proteolysis. Here, we identified that the α-helical structural region of hydrophilic loop 1 (HL1) and the C-terminal region of human PS1 are distinct substrate-binding sites. Mutational analyses revealed that substrate binding to the HL1 region is critical for both ε- and γ-cleavage, whereas binding to the C-terminal region hampers γ-cleavage. Moreover, we propose that substrate binding triggers conformational changes in PS1, rendering it suitable for catalysis. Our data provide new insights into the complicated catalytic mechanism of PS1.

[1]  Takeshi Iwatsubo,et al.  Allosteric regulation of γ-secretase activity by a phenylimidazole-type γ-secretase modulator , 2014, Proceedings of the National Academy of Sciences.

[2]  Yanyu Zhao,et al.  Three-dimensional structure of human γ-secretase , 2014, Nature.

[3]  J. Takagi,et al.  A structure-based model of substrate discrimination by a noncanonical PDZ tandem in the intramembrane-cleaving protease RseP. , 2014, Structure.

[4]  B. Hyman,et al.  Structural Interactions between Inhibitor and Substrate Docking Sites Give Insight into Mechanisms of Human PS1 Complexes , 2014, Structure.

[5]  B. Permanne,et al.  Substrate determinants in the C99 juxtamembrane domains differentially affect γ–secretase cleavage specificity and modulator pharmacology , 2013, Journal of neurochemistry.

[6]  Y. Ha,et al.  Structure and Mechanism of Rhomboid Protease* , 2013, The Journal of Biological Chemistry.

[7]  T. Iwatsubo,et al.  Structural Biology of Presenilins and Signal Peptide Peptidases* , 2013, The Journal of Biological Chemistry.

[8]  R. Soong,et al.  When detergent meets bilayer: birth and coming of age of lipid bicelles. , 2013, Progress in nuclear magnetic resonance spectroscopy.

[9]  Yigong Shi,et al.  Structure of a presenilin family intramembrane aspartate protease , 2012, Nature.

[10]  T. Iwatsubo,et al.  Contribution of the γ-Secretase Subunits to the Formation of Catalytic Pore of Presenilin 1 Protein* , 2012, The Journal of Biological Chemistry.

[11]  B. de Strooper,et al.  Peptides based on the presenilin‐APP binding domain inhibit APP processing and Aβ production through interfering with the APP transmembrane domain , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  P. Wong,et al.  Neutralization of the γ-secretase activity by monoclonal antibody against extracellular domain of nicastrin , 2012, Oncogene.

[13]  T. Iwatsubo,et al.  Phenylpiperidine‐type γ‐secretase modulators target the transmembrane domain 1 of presenilin 1 , 2011, The EMBO journal.

[14]  T. Golde,et al.  Lysine 624 of the Amyloid Precursor Protein (APP) Is a Critical Determinant of Amyloid β Peptide Length , 2011, The Journal of Biological Chemistry.

[15]  Sangwon Lee,et al.  The crystal structure of GXGD membrane protease FlaK , 2011, Nature.

[16]  J. Morris,et al.  Alzheimer’s Disease: The Challenge of the Second Century , 2011, Science Translational Medicine.

[17]  T. Iwatsubo,et al.  Participation of Transmembrane Domain 1 of Presenilin 1 in the Catalytic Pore Structure of the γ-Secretase , 2010, The Journal of Neuroscience.

[18]  T. Iwatsubo,et al.  Functional Analysis of the Transmembrane Domains of Presenilin 1 , 2010, The Journal of Biological Chemistry.

[19]  Yue-Ming Li,et al.  An APP inhibitory domain containing the Flemish mutation residue modulates γ-secretase activity for Aβ production , 2010, Nature Structural &Molecular Biology.

[20]  Y. Ihara,et al.  γ-Secretase: Successive Tripeptide and Tetrapeptide Release from the Transmembrane Domain of β-Carboxyl Terminal Fragment , 2009, The Journal of Neuroscience.

[21]  T. Iwatsubo,et al.  Inhibition of gamma-secretase activity by helical beta-peptide foldamers. , 2009, Journal of the American Chemical Society.

[22]  J. Prestegard,et al.  Structural studies of the transmembrane C-terminal domain of the amyloid precursor protein (APP): does APP function as a cholesterol sensor? , 2008, Biochemistry.

[23]  B. de Strooper,et al.  Transmembrane Domain 9 of Presenilin Determines the Dynamic Conformation of the Catalytic Site of γ-Secretase* , 2008, Journal of Biological Chemistry.

[24]  T. Iwatsubo,et al.  The C-Terminal PAL Motif and Transmembrane Domain 9 of Presenilin 1 Are Involved in the Formation of the Catalytic Pore of the γ-Secretase , 2008, The Journal of Neuroscience.

[25]  Christian Cole,et al.  The Jpred 3 secondary structure prediction server , 2008, Nucleic Acids Res..

[26]  Richard M. Page,et al.  Generation of Aβ38 and Aβ42 Is Independently and Differentially Affected by Familial Alzheimer Disease-associated Presenilin Mutations and γ-Secretase Modulation* , 2008, Journal of Biological Chemistry.

[27]  D. Schenk,et al.  Amyloid β-Protein Precursor Juxtamembrane Domain Regulates Specificity of γ-Secretase-dependent Cleavages* , 2007, Journal of Biological Chemistry.

[28]  C. Nichols,et al.  Control of Inward Rectifier K Channel Activity by Lipid Tethering of Cytoplasmic Domains , 2007, The Journal of general physiology.

[29]  S. Tsuji,et al.  Aβ42 Overproduction Associated with Structural Changes in the Catalytic Pore of γ-Secretase , 2007, Journal of Biological Chemistry.

[30]  T. Iwatsubo,et al.  Structure of the Catalytic Pore of γ-Secretase Probed by the Accessibility of Substituted Cysteines , 2006, The Journal of Neuroscience.

[31]  S. McLaughlin,et al.  Structure of the membrane reconstituted transmembrane-juxtamembrane peptide EGFR(622-660) and its interaction with Ca2+/calmodulin. , 2006, Biochemistry.

[32]  B. de Strooper,et al.  Contribution of Presenilin Transmembrane Domains 6 and 7 to a Water-containing Cavity in the γ-Secretase Complex* , 2006, Journal of Biological Chemistry.

[33]  B. de Strooper,et al.  Presenilin-1 Maintains a Nine-Transmembrane Topology throughout the Secretory Pathway* , 2006, Journal of Biological Chemistry.

[34]  T. Iwatsubo,et al.  C-terminal Fragment of Presenilin Is the Molecular Target of a Dipeptidic γ-Secretase-specific Inhibitor DAPT (N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-Butyl Ester)* , 2006, Journal of Biological Chemistry.

[35]  T. Iwatsubo,et al.  Pen-2 Is Incorporated into the γ-Secretase Complex through Binding to Transmembrane Domain 4 of Presenilin 1* , 2005, Journal of Biological Chemistry.

[36]  A. Takashima,et al.  Reconstitution of γ‐secretase by truncated presenilin (PS) fragments revealed that PS C‐terminal transmembrane domain is critical for formation of γ‐secretase complex , 2005 .

[37]  Young Oh,et al.  Evidence that the COOH terminus of human presenilin 1 is located in extracytoplasmic space. , 2005, American journal of physiology. Cell physiology.

[38]  M. Wolfe,et al.  The initial substrate-binding site of γ-secretase is located on presenilin near the active site , 2005 .

[39]  F. Kametani,et al.  Longer Forms of Amyloid β Protein: Implications for the Mechanism of Intramembrane Cleavage by γ-Secretase , 2005, The Journal of Neuroscience.

[40]  C. Haass,et al.  The presenilin C‐terminus is required for ER‐retention, nicastrin‐binding and γ‐secretase activity , 2004, The EMBO journal.

[41]  T. Iwatsubo,et al.  Parallel synthesis of DAPT derivatives and their γ-secretase-inhibitory activity , 2004 .

[42]  T. Kitamura,et al.  Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. , 2003, Experimental hematology.

[43]  B. Hyman,et al.  Designed helical peptides inhibit an intramembrane protease. , 2003, Journal of the American Chemical Society.

[44]  T. Iwatsubo,et al.  Sulindac Sulfide Is a Noncompetitive γ-Secretase Inhibitor That Preferentially Reduces Aβ42 Generation* , 2003, The Journal of Biological Chemistry.

[45]  T. Iwatsubo,et al.  The role of presenilin cofactors in the γ-secretase complex , 2003, Nature.

[46]  N. Perrimon,et al.  γ‐Secretase/presenilin inhibitors for Alzheimer's disease phenocopy Notch mutations in Drosophila , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  B. Strooper,et al.  Interaction with Telencephalin and the Amyloid Precursor Protein Predicts a Ring Structure for Presenilins , 2001, Neuron.

[48]  Liam J. McGuffin,et al.  The PSIPRED protein structure prediction server , 2000, Bioinform..

[49]  T. Iwatsubo,et al.  C Terminus of Presenilin Is Required for Overproduction of Amyloidogenic Aβ42 through Stabilization and Endoproteolysis of Presenilin , 1999, The Journal of Neuroscience.

[50]  C. Sanders,et al.  Bicelles: a model membrane system for all seasons? , 1998, Structure.

[51]  H. Feirabend,et al.  Preservation and staining of myelinated nerve fibers. , 1998, Methods.

[52]  C. L. Harris,et al.  Stable Association of Presenilin Derivatives and Absence of Presenilin Interactions with APP , 1998, Neurobiology of Disease.

[53]  J. Buxbaum,et al.  A novel Polish presenilin‐1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years , 1998, NeuroReport.

[54]  T. Iwatsubo,et al.  The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[55]  D. Borchelt,et al.  Protein Topology of Presenilin 1 , 1996, Neuron.

[56]  Richard M. Page,et al.  Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation. , 2008, The Journal of biological chemistry.

[57]  D. Schenk,et al.  Amyloid beta-protein precursor juxtamembrane domain regulates specificity of gamma-secretase-dependent cleavages. , 2007, The Journal of biological chemistry.

[58]  S. Tsuji,et al.  Abeta42 overproduction associated with structural changes in the catalytic pore of gamma-secretase: common effects of Pen-2 N-terminal elongation and fenofibrate. , 2007, The Journal of biological chemistry.

[59]  A. Takashima,et al.  Reconstitution of gamma-secretase by truncated presenilin (PS) fragments revealed that PS C-terminal transmembrane domain is critical for formation of gamma-secretase complex. , 2006, Genes to cells : devoted to molecular & cellular mechanisms.

[60]  F. Kametani,et al.  Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase. , 2005, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[61]  M. Wolfe,et al.  The initial substrate-binding site of gamma-secretase is located on presenilin near the active site. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[62]  T. Iwatsubo,et al.  Parallel synthesis of DAPT derivatives and their gamma-secretase-inhibitory activity. , 2004, Bioorganic & medicinal chemistry letters.

[63]  T. Iwatsubo,et al.  The role of presenilin cofactors in the gamma-secretase complex. , 2003, Nature.

[64]  T. Iwatsubo,et al.  Sulindac sulfide is a noncompetitive gamma-secretase inhibitor that preferentially reduces Abeta 42 generation. , 2003, The Journal of biological chemistry.

[65]  B. de Strooper,et al.  Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells. , 2000, Nature Cell Biology.

[66]  A. Karlin,et al.  Substituted-cysteine accessibility method. , 1998, Methods in enzymology.